C4 Therapeutics to Participate in Upcoming March Conferences

Company Overview - C4 Therapeutics, Inc. (C4T) is a clinical-stage biopharmaceutical company focused on advancing targeted protein degradation (TPD) science to create innovative medicines that can transform patients' lives [3] - The company is developing targeted oncology programs through clinical studies and utilizes its TORPEDO platform to design and optimize small-molecule medicines for challenging diseases [3] - C4T's degrader medicines aim to leverage the body's natural protein recycling system to degrade disease-causing proteins, potentially addressing drug resistance and improving patient outcomes [3] Upcoming Events - C4T management will participate in the Barclays 28 Annual Global Healthcare Conference on March 10, 2026, at 8:00 AM ET in Miami, Florida, featuring a fireside chat [2] - The company will also present at the TD Cowen 46 Annual Healthcare Conference on March 3, 2026, at 11:50 AM ET in Boston, Massachusetts, where management will engage in a fireside chat [4]